GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a remarkable development in how we approach type 2 diabetes . These injectable therapies work by stimulating the body’s inherent https://getsocialnetwork.com/story7284572/glp-1-a-revolutionary-advance-in-diabetes-management